Fears Of Recession Mount As Coronavirus Declared A Pandemic
Biopharma Determined To Maintain Clinical Trials, Drug Launches
Investor sentiment still backing growth for pharma and biotech sectors, but the length and severity of COVID-19's impact globally has yet to be seen.
You may also be interested in...
Funded by the US government since March 2018, the Vancouver-based company aims to have an antibody therapy ready for clinical trials within four months.
Its ‘virus chasing’ habits has given Inovio a bad reputation. But with backing from CEPI and Bill Gates, it has a chance to prove the doubters wrong.
Investment from Janssen helps to validate the platform developed by the San Diego-based company.